Canaccord analyst Gary Nachmann reiterated a Buy rating and $13.00 price target on Achieve Life Sciences (NASDAQ: ACHV).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments